Concurrently, it has been reported that the ISG15 pathway (ISG15 and its conjugating enzymes) is overexpressed in human breast cancer cells and clinical specimens [70,71,152,153] and inhibits protein degradation in cancer cells [70]. Here, ISG15 is linked to cancer.